Free Trial

SS Innovations International (SSII) Competitors

SS Innovations International logo
$1.66 +0.34 (+25.76%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$1.62 -0.04 (-2.71%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SSII vs. ESTA, KMTS, OMCL, BFLY, and NVCR

Should you buy SS Innovations International stock or one of its competitors? SS Innovations International's main competitors and comparable companies include Establishment Labs (ESTA), Kestra Medical Technologies (KMTS), Omnicell (OMCL), Butterfly Network (BFLY), and NovoCure (NVCR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SS Innovations International compare to Establishment Labs?

SS Innovations International (NASDAQ:SSII) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

In the previous week, SS Innovations International had 2 more articles in the media than Establishment Labs. MarketBeat recorded 6 mentions for SS Innovations International and 4 mentions for Establishment Labs. SS Innovations International's average media sentiment score of 0.91 beat Establishment Labs' score of 0.75 indicating that SS Innovations International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Establishment Labs
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SS Innovations International has a beta of -1.52, meaning that its stock price is 252% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

SS Innovations International has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than SS Innovations International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M7.83-$12.13M-$0.06N/A
Establishment Labs$211.08M10.00-$51.06M-$1.28N/A

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 321.69%. Establishment Labs has a consensus price target of $95.00, indicating a potential upside of 34.28%. Given SS Innovations International's higher probable upside, research analysts clearly believe SS Innovations International is more favorable than Establishment Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Establishment Labs
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80

Establishment Labs has a net margin of -14.56% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
Establishment Labs -14.56%-196.38%-10.45%

Summary

Establishment Labs beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Kestra Medical Technologies?

SS Innovations International (NASDAQ:SSII) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

SS Innovations International has a net margin of -23.73% compared to Kestra Medical Technologies' net margin of -140.43%. SS Innovations International's return on equity of -26.77% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
Kestra Medical Technologies -140.43%-63.83%-44.76%

In the previous week, SS Innovations International had 3 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 6 mentions for SS Innovations International and 3 mentions for Kestra Medical Technologies. SS Innovations International's average media sentiment score of 0.91 beat Kestra Medical Technologies' score of 0.74 indicating that SS Innovations International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Kestra Medical Technologies
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SS Innovations International has higher earnings, but lower revenue than Kestra Medical Technologies. SS Innovations International is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M7.83-$12.13M-$0.06N/A
Kestra Medical Technologies$95.13M17.93-$131.61M-$2.67N/A

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 321.69%. Kestra Medical Technologies has a consensus price target of $29.00, indicating a potential upside of 1.26%. Given SS Innovations International's higher probable upside, equities research analysts clearly believe SS Innovations International is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

SS Innovations International has a beta of -1.52, indicating that its stock price is 252% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Summary

SS Innovations International beats Kestra Medical Technologies on 8 of the 14 factors compared between the two stocks.

How does SS Innovations International compare to Omnicell?

Omnicell (NASDAQ:OMCL) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

97.7% of Omnicell shares are owned by institutional investors. 2.9% of Omnicell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Omnicell has a net margin of 3.59% compared to SS Innovations International's net margin of -23.73%. Omnicell's return on equity of 5.69% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
Omnicell3.59% 5.69% 3.61%
SS Innovations International -23.73%-26.77%-15.01%

In the previous week, SS Innovations International had 3 more articles in the media than Omnicell. MarketBeat recorded 6 mentions for SS Innovations International and 3 mentions for Omnicell. Omnicell's average media sentiment score of 0.98 beat SS Innovations International's score of 0.91 indicating that Omnicell is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omnicell
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Omnicell has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omnicell$1.18B1.36$2.05M$0.9636.49
SS Innovations International$42.49M7.83-$12.13M-$0.06N/A

Omnicell has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.52, suggesting that its share price is 252% less volatile than the broader market.

Omnicell currently has a consensus price target of $57.86, suggesting a potential upside of 65.16%. SS Innovations International has a consensus price target of $7.00, suggesting a potential upside of 321.69%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than Omnicell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omnicell
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.90
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Omnicell beats SS Innovations International on 14 of the 17 factors compared between the two stocks.

How does SS Innovations International compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

SS Innovations International has a net margin of -23.73% compared to Butterfly Network's net margin of -43.56%. Butterfly Network's return on equity of -21.60% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-43.56% -21.60% -14.25%
SS Innovations International -23.73%-26.77%-15.01%

In the previous week, Butterfly Network had 3 more articles in the media than SS Innovations International. MarketBeat recorded 9 mentions for Butterfly Network and 6 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.91 beat Butterfly Network's score of 0.27 indicating that SS Innovations International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

SS Innovations International has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than SS Innovations International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$97.61M16.65-$77.06M-$0.21N/A
SS Innovations International$42.49M7.83-$12.13M-$0.06N/A

Butterfly Network currently has a consensus target price of $8.75, suggesting a potential upside of 44.03%. SS Innovations International has a consensus target price of $7.00, suggesting a potential upside of 321.69%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Butterfly Network has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.52, suggesting that its stock price is 252% less volatile than the broader market.

37.9% of Butterfly Network shares are held by institutional investors. 22.0% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Butterfly Network beats SS Innovations International on 11 of the 17 factors compared between the two stocks.

How does SS Innovations International compare to NovoCure?

NovoCure (NASDAQ:NVCR) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

84.6% of NovoCure shares are owned by institutional investors. 6.6% of NovoCure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SS Innovations International has lower revenue, but higher earnings than NovoCure. SS Innovations International is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NovoCure$655.35M2.11-$136.23M-$1.06N/A
SS Innovations International$42.49M7.83-$12.13M-$0.06N/A

NovoCure presently has a consensus target price of $22.33, indicating a potential upside of 88.79%. SS Innovations International has a consensus target price of $7.00, indicating a potential upside of 321.69%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than NovoCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NovoCure
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, NovoCure had 11 more articles in the media than SS Innovations International. MarketBeat recorded 17 mentions for NovoCure and 6 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.91 beat NovoCure's score of -0.04 indicating that SS Innovations International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NovoCure
1 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

NovoCure has a net margin of -16.78% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat NovoCure's return on equity.

Company Net Margins Return on Equity Return on Assets
NovoCure-16.78% -35.81% -15.14%
SS Innovations International -23.73%-26.77%-15.01%

NovoCure has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.52, indicating that its share price is 252% less volatile than the broader market.

Summary

NovoCure beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSII vs. The Competition

MetricSS Innovations InternationalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$264.51M$5.98B$7.87B$12.20B
Dividend YieldN/A1.68%2.46%4.53%
P/E Ratio-27.6739.3334.5630.66
Price / Sales7.835.598.645.86
Price / CashN/A23.9521.9322.49
Price / Book8.304.454.353.76
Net Income-$12.13M$143.92M$3.52B$390.95M
7 Day Performance-21.33%-1.14%-1.52%-0.34%
1 Month Performance-35.66%-2.38%-3.54%-5.79%
1 Year Performance-73.31%1.91%1.45%-5.71%

SS Innovations International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSII
SS Innovations International
2.2602 of 5 stars
$1.66
+25.8%
$7.00
+321.7%
N/A$264.51M$42.49MN/A483
ESTA
Establishment Labs
3.3604 of 5 stars
$67.02
+4.0%
$95.00
+41.7%
N/A$1.82B$211.08MN/A1,004
KMTS
Kestra Medical Technologies
1.1193 of 5 stars
$28.80
+0.9%
$29.00
+0.7%
N/A$1.78B$95.13MN/A443
OMCL
Omnicell
3.2025 of 5 stars
$37.34
-1.8%
$57.86
+54.9%
N/A$1.66B$1.18B38.903,580
BFLY
Butterfly Network
3.1763 of 5 stars
$6.37
+4.9%
$8.75
+37.4%
N/A$1.63B$97.61MN/A220

Related Companies and Tools


This page (NASDAQ:SSII) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners